Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

Journal of Clinical Investigation

Volumn 106, Issue 12, 2000, Pages 1553-1560

  Falahati Nini, A ^a   Riggs, B L ^a   Atkinson, E J ^a   O'Fallon, W M ^a   Eastell, R ^a   Khosla, S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; OSTEOCALCIN;

AGED; AGING; ARTICLE; CONTROLLED STUDY; ESTROGEN SYNTHESIS; HORMONAL REGULATION; HUMAN; MALE; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; TESTOSTERONE SYNTHESIS;

EID: 0034521393     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10942     Document Type: Article

References (58)

1. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
2. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
3. Effect of testosterone and estradiol in a man with aromatase deficiency
4. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
5. Estrogen replacement therapy in a man with congenital aromatase deficiency: Effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters
6. Sex steroids and bone mass in older men: Positive associations with serum estrogens and negative associations with androgens
7. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study
8. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
9. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males
10. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men
11. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry
12. Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo Osteoporosis Epidemiology Study
13. Total and regional bone mineral density in men: Effect of age
14. Cross-sectional versus longitudinal evaluation of bone loss in men and women
15. Testosterone transdermal system
16. Estradiol transdermal system
17. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography
18. Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders
19. The G.L.M. procedure
20. Androgens regulate bone resorption activity of isolated osteoclasts in vitro
21. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens
22. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line
23. Production and characterization of an antibody against the human bone GLA protein (BGP/osteocalcin) propeptide and its use in immunocytochemistry of bone cells
24. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone
25. Like estrogen, androgens exert potent and direct anti-apoptotic effects on osteoblasts and osteocytes in vivo and in vitro
26. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
27. Bone formation: Osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process
28. Turnover rate of skeletal alkaline phosphatase in humans
29. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability
30. Preventive effects of transdermal 17beta-estradiol on osteoporotic changes after surgical menopause: A 2-year placebo-controlled trial
31. Castrated men exhibit bone loss. Effect of calcitonin treatment on biochemical indices of bone remodeling
32. Menopausal changes in bone remodeling
33. Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy
34. Mechanism of renal calcium conservation with estrogen replacement therapy in early postmenopausal women: A clinical research center study
35. Effect of estrogen status on bone regulating hormones
36. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
37. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton
38. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
39. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
40. 3 in oophorectomized women
41. Testosterone alters duodenal calcium transport and longitudinal bone growth rate in parallel in the male rat
42. Effects of dihydrotestosterone on bone biochemical markers in sham and oophorectomized rats
43. Aromatization of androgens is important for skeletal maintenance of aged male rats
44. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes
45. Bone has a sexually dimorphic response to aromatase deficiency
46. Androgen deficiency induces high turnover osteopenia in aged male rats: A sequential histomorphometric study
47. Bone and mineral metabolism in aged male rats: Short and long term effects of androgen deficiency
48. 5 Alpha-dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats
49. Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats
50. Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780
51. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat
52. Osteopenia as a feature of the androgen insensitivity syndrome
53. Altered bone mineral density in patients with complete androgen insensitivity syndrome
54. The contribution of testosterone to skeletal development and maintenance: Lessons from the androgen insensitivity syndrome
55. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats
56. Factors affecting bone density in young adults
57. The effect of estrogen therapy on older men with low bone mass
58. Androgen supplementation in eugonadal men with osteoporosis: Effects of six months' treatment on markers of bone formation and resorption